The Latest Cardiac and Vascular News
BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Kevin Hrusovsky, Chairman and CEO of Quanterix, and Founder of Powering Precision Health (PPH), has been recognized with the Entrepreneur Of The Year® 2019 Award in the New […]
VANCOUVER, British Columbia, June 29, 2019 (GLOBE NEWSWIRE) — Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) is pleased to announce that it has completed its previously announced acquisition (the “Acquisition”) of all of the shares of Xellera Therapeutics Limited (“XT”). As consideration for the Acquisition, Novoheart has issued […]
Santa Monica, CA, July 01, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ:BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that it has been added as a member of the broad-market Russell 3000® Index, […]
ENGLEWOOD, Colo., July 1, 2019 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has been included in the Russell 2000 Index following reconstitution of Russell indices on June 28th. Zynex will […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that the Company will join the broad-market Russell 3000® Index at the conclusion of the 2019 Russell indexes annual reconstitution, effective after the US market opens on July 1. Annual […]
PARIS and NEW YORK, June 27, 2019 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat resistant hypertension and heart failure, informs its shareholders that […]
DUBLIN, June 25, 2019 (GLOBE NEWSWIRE) — Medtronic plc (the “Company”) (NYSE:MDT) today announced the upsizing of the previously announced cash tender offer (the “Maximum Tender Offer”) by its wholly-owned indirect subsidiaries, Medtronic, Inc., Medtronic Global Holdings S.C.A. (“MGH”) and Covidien International Finance S.A. (“CIFSA” and, together with Medtronic, Inc. […]
MARLBOROUGH, Mass., June 26, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) is hosting a meeting with the investment community today in New York City to review its business and long-term growth strategies. The company is presenting plans for its product pipeline and strategic investments to enable improved clinical and economic outcomes, sustain category leadership […]
VANCOUVER, June 25, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ:NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that it has received written notification (the “Nasdaq […]
NATIONAL HARBOR, Md.–(BUSINESS WIRE)–Health Prime, a leading provider of revenue cycle management services, today announced that East Bay Cardiovascular and Thoracic Associates, a premier multi-specialty surgical group, has signed a partnership agreement for revenue cycle management services. Health Prime was brought onboard to scale operations and optimize current revenue opportunities. […]
